NOVARTIND.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Oct 2023 @ 06:00):

Stats
Today's Volume	11 685.00
Average Volume	5 696.00
Market Cap	16.64B
EPS	INR10.76 ( 2024-02-13 )
Next earnings date	( INR0 ) 2024-05-10
Last Dividend	INR37.50 ( 2023-07-20 )
Next Dividend	INR0 ( N/A )
P/E	21.75
ATR14	INR12.22 (1.82%)

Volume Correlation

Long: 0.74 (moderate)

Short: 0.00 (neutral)

Signal:(25.341) Neutral

Novartis India Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Novartis India Limited Correlation - Currency/Commodity

0.07
( neutral )

-0.02
( neutral )

-0.60
( weak negative )

-0.48
( neutral )

0.20
( neutral )

0.13
( neutral )

Novartis India Limited Financials

Annual	2022
Revenue:	INR3.79B
Gross Profit:	INR1.77B (46.75 %)
EPS:	INR41.86

FY	2022
Revenue:	INR3.79B
Gross Profit:	INR1.77B (46.75 %)
EPS:	INR41.86

FY	2022
Revenue:	INR3.88B
Gross Profit:	INR2.06B (53.18 %)
EPS:	INR-1.510

FY	2021
Revenue:	INR3.66B
Gross Profit:	INR2.16B (59.07 %)
EPS:	INR8.46

Financial Reports:

No articles found.

Novartis India Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR37.50 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Novartis India Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.04 - low (34.25%) | Divividend Growth Potential Score: 4.13 - Stable (17.39%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR10.00	2021-08-17
Last Dividend	INR37.50	2023-07-20
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	INR57.50	--
Avg. Dividend % Per Year	2.07%	--
Score	2.58	--
Div. Sustainability Score	4.04
Div.Growth Potential Score	4.13
Div. Directional Score	4.08	--

Next Divdend (Est)
(2024-07-01)

INR65.00 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.58

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2021	INR10.00	1.45%
2022	INR10.00	1.28%
2023	INR37.50	5.57%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMLT.NS	Dividend Knight	2023-08-09	Semi-Annually	3	0.64%
MIDHANI.NS	Dividend Junior	2023-09-22	Semi-Annually	7	1.04%
HAVELLS.NS	Dividend Junior	2023-06-02	Annually	23	0.43%
BECTORFOOD.NS	Dividend Junior	2023-09-22	Semi-Annually	4	0.39%
PUNJABCHEM.NS	Dividend Junior	2023-07-27	Sporadic	18	0.16%
KENNAMET.NS	Dividend Knight	2023-05-25	Annually	4	0.76%
ELECTCAST.NS	Dividend Junior	2023-09-04	Annually	23	1.51%
AHLUCONT.NS	Dividend Junior	2023-09-22	Sporadic	15	0.04%
SUNPHARMA.NS	Dividend Knight	2023-07-28	Semi-Annually	29	0.77%
NAVA.NS	Dividend Junior	2023-07-24	Annually	23	2.35%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.289	1.500	4.21	6.32	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.129	1.500	9.67	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	70.26	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	2.16	2.00	9.28	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.16	2.00	8.92	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.427	1.000	6.21	6.21	[0.2 - 0.8]
operatingProfitMarginTTM	0.347	1.000	5.06	5.06	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.04

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	17.42	1.000	8.34	0	[1 - 100]
returnOnEquityTTM	0.129	2.50	9.79	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.16	2.00	9.28	10.00	[0 - 30]
dividendYielPercentageTTM	5.56	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.16	2.00	9.28	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00607	1.500	-3.29	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0162	1.000	-2.10	0	[0.1 - 0.5]
Total Score				4.13

Novartis India Limited

Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.